Vitamin K is one of the less talked-about nutrients in prenatal care, yet it plays a central role in blood clotting, bone development, and the health of both mother and baby. Unlike folic acid or iron, vitamin K rarely appears on the list of supplements your OB hands you at the first visit. That relative silence masks a more complicated story, particularly around how little of this vitamin actually reaches your baby before birth and what that means for the first days and weeks of life.
What Vitamin K Actually Does in Your Body
Vitamin K is best known for making blood clot properly. Without it, even a minor cut or internal bruise can bleed longer than it should. But clotting is only part of the picture. The vitamin activates a family of proteins involved in bone metabolism and the regulation of calcium in blood vessels and tissues. These vitamin K-dependent proteins go through a chemical modification called carboxylation, carried out by an enzyme in cells, that allows them to bind calcium and do their jobs. Recent structural biology work has mapped out how this enzyme recognizes and processes its target proteins, confirming that the same basic machinery handles clotting factors, bone proteins like osteocalcin, and proteins that keep calcium out of soft tissues where it doesn’t belong.1Nature Communications. Structural insight into bicarbonate-mediated carboxylation by human vitamin K-dependent carboxylase
During pregnancy, this matters doubly. Your blood volume increases substantially, your skeleton is lending minerals to a growing fetus, and the proteins that manage all of this need vitamin K to function. Meanwhile, your baby is building an entire skeletal system from scratch, and several of the key proteins involved in cartilage and bone development are vitamin K-dependent.2PubMed Central. Vitamin K-Dependent Proteins in Skeletal Development and Disease
How Much You Need and Where to Get It
The European Food Safety Authority sets the adequate intake for vitamin K (specifically phylloquinone, the plant form known as K1) at 70 micrograms per day for all adults, and that number does not change for pregnant or lactating women.3PubMed Central. Dietary reference values for vitamin K The U.S. recommendation is similar, at 90 micrograms per day for adult women. These figures are modest compared to what a single serving of many leafy greens provides. A cup of cooked spinach or kale delivers several times the daily target, and broccoli, Brussels sprouts, and lettuce are also reliable sources. Smaller amounts come from vegetable oils (soybean and canola), some fermented foods, and animal products like liver and egg yolks.
Vitamin K2, the other main form (called menaquinone), is found in fermented foods like natto, certain cheeses, and is also produced by gut bacteria. K2 has drawn particular interest for bone health, but it tends to appear in smaller quantities in a typical Western diet. Most people who eat a reasonably varied diet that includes green vegetables are getting enough total vitamin K without supplements, and prenatal vitamins do not always include it. If you eat few vegetables, have a restricted diet, or deal with fat-malabsorption conditions like Crohn’s disease or celiac disease, your intake could fall short.
The Placenta Problem
Here is the part that surprises most expectant parents: no matter how well you eat, your baby is born with very little vitamin K. Measurements of vitamin K1 in umbilical cord blood show levels far below what circulates in maternal blood. The concentration gradient between mother and newborn is large, indicating that vitamin K does not cross the placenta efficiently. Researchers have proposed that this may be due to low levels of the lipoprotein that carries vitamin K in fetal blood, essentially meaning the baby’s circulation lacks the transport system to pull the vitamin across.4PubMed. Plasma vitamin K1 in mothers and their newborn babies
This poor placental transfer is not something you can fix by taking extra vitamin K during pregnancy. A Cochrane review looking for randomized controlled trials of vitamin K supplementation during pregnancy found none, meaning there is no trial evidence that giving pregnant women additional vitamin K improves their baby’s vitamin K status at birth or prevents bleeding complications afterward.5PubMed Central. Vitamin K supplementation during pregnancy for improving outcomes The lack of trials is itself telling: the placental barrier is so effective at keeping vitamin K levels low in the fetus that supplementing the mother has not been demonstrated to reliably change the equation. This is why the focus shifts to the baby after birth.
Why Newborns Get a Vitamin K Shot
Because babies arrive with minimal vitamin K stores and their gut bacteria have not yet colonized enough to produce meaningful amounts, they are vulnerable to a condition called vitamin K deficiency bleeding (VKDB). This bleeding disorder is classified into three windows: early (within the first 24 hours), classic (within the first week), and late (between two weeks and six months of age).6PubMed Central. Vitamin K Deficiency Bleeding in Infancy The late form is particularly dangerous because it often involves bleeding into the brain and can occur in apparently healthy, thriving infants.
The standard prevention is a single intramuscular injection of 1 milligram of vitamin K1 given shortly after birth. This approach has been used since the mid-twentieth century, and surveillance data consistently show near-complete protection against both classic and late VKDB when the injection is given.7PubMed Central. Vitamin K Prophylaxis in Newborns: A Narrative Review of the Molecular Basis, Clinical Evidence, and Comparative Effectiveness of Intramuscular Versus Oral Administration and Parental Hesitation The intramuscular route creates a depot of the vitamin in the muscle tissue that releases slowly over weeks, bridging the gap until the infant starts producing its own supply through gut bacteria and dietary intake.
Oral vitamin K regimens exist as well. The European Society for Paediatric Gastroenterology, Hepatology and Nutrition recommends that if parents decline the injection, alternatives include three oral doses of 2 milligrams (at birth, at four to six days, and at four to six weeks) or 2 milligrams at birth followed by 1 milligram weekly for three months. But the society is clear that injection remains the preferred route because oral regimens depend on parents completing every dose on schedule, and compliance in real-world settings is uneven.7PubMed Central. Vitamin K Prophylaxis in Newborns: A Narrative Review of the Molecular Basis, Clinical Evidence, and Comparative Effectiveness of Intramuscular Versus Oral Administration and Parental Hesitation A missed dose leaves the baby partially unprotected, and the late-onset form of VKDB has been reported even in countries with established oral protocols when doses were skipped.
The Cancer Scare That Did Not Hold Up
Some parents hesitate about the vitamin K shot because of a decades-old concern linking it to childhood cancer. This originated from a single study published in the early 1990s that suggested a possible association between intramuscular vitamin K and leukemia. The claim generated enormous attention and prompted multiple large investigations. The United Kingdom Childhood Cancer Study, one of the most comprehensive follow-ups, found no association between intramuscular vitamin K and leukemia or any other childhood cancer.8PubMed Central. Vitamin K and childhood cancer: a report from the United Kingdom Childhood Cancer Study
Reviews of the accumulated evidence have consistently reached the same conclusion: there is no convincing evidence that neonatal vitamin K administration, regardless of whether it is given by injection or orally, influences cancer risk.9PubMed Central. Controversies surrounding the administration of vitamin K to newborns: a review The original alarm was a statistical artifact that did not replicate. It is worth mentioning because it still circulates online and in some parenting communities, and declining the shot based on this fear carries a real risk: VKDB, while rare when prophylaxis is given, can cause permanent brain damage or death when it occurs.
When Pregnancy Itself Causes Deficiency
Most pregnant women who eat a varied diet maintain adequate vitamin K levels. But certain pregnancy complications can tip the balance. Hyperemesis gravidarum, the severe form of pregnancy nausea and vomiting that goes well beyond typical morning sickness, is one of the clearest risk factors. A systematic review examining this link found that among women hospitalized for hyperemesis, a substantial proportion showed prolonged clotting times consistent with vitamin K deficiency. In one cohort study within the review, roughly a quarter of women tested had prolonged prothrombin time. Case reports documented maternal bleeding complications and, in severe untreated cases, neonatal complications including intracranial hemorrhage and skeletal abnormalities.10PubMed Central. Hyperemesis gravidarum and vitamin K deficiency: a systematic review
The skeletal abnormalities are particularly striking. Some case reports described a pattern called chondrodysplasia punctata, where calcification appears in abnormal spots on developing cartilage, along with nasal underdevelopment (Binder phenotype). These are associated with prolonged, severe vitamin K depletion during the critical period of fetal skeletal development. The takeaway for anyone dealing with hyperemesis is that vitamin K status should be monitored, and supplementation may be warranted when oral intake is severely compromised for weeks.
Medications That Interfere with Vitamin K
Certain drugs taken during pregnancy can worsen the vitamin K picture for the baby. Anticonvulsant medications, used by women with epilepsy, are the best-studied example. Research comparing cord blood from newborns whose mothers took anticonvulsants to those from unexposed pregnancies found a markedly higher rate of detectable PIVKA-II (a marker of vitamin K deficiency) in the anticonvulsant group: about half of exposed newborns showed this marker, compared to about a fifth in controls. Maternal vitamin K1 levels were also lower in women taking these medications.11PubMed. Increased incidence of neonatal vitamin K deficiency resulting from maternal anticonvulsant therapy
The mechanism involves liver enzyme induction: anticonvulsants like phenytoin, carbamazepine, and phenobarbital speed up the breakdown of vitamin K in the mother’s system. Other medications can interact with vitamin K as well, including warfarin (which works by directly blocking the vitamin K cycle, and is rarely used in pregnancy for this reason), certain antibiotics that disrupt gut bacteria, and cholestyramine, a bile acid binder that reduces fat-soluble vitamin absorption. If you are on any medication that affects liver enzymes or fat absorption, your provider should be monitoring your coagulation status and potentially recommending supplementation in the final weeks of pregnancy.
Vitamin K2 and Bone Health for Mother and Baby
While vitamin K1 gets most of the attention for its role in clotting, K2 has emerged as a focus of bone health research during pregnancy. A study measuring maternal vitamin K2 levels in late pregnancy found that deficiency was common and was associated with changes in bone metabolism markers in both the mother and the newborn. Specifically, mothers deficient in K2 had higher levels of osteocalcin (a vitamin K-dependent bone protein), which sounds counterintuitive until you understand that elevated osteocalcin can indicate increased bone turnover, suggesting the skeleton is actively losing mineral. Their newborns showed similar patterns.12PubMed Central. Association Between Maternal Vitamin K2 Levels in Late Pregnancy and Newborn Bone Metabolism
This fits with what we know about osteocalcin from other research: it needs vitamin K to undergo the carboxylation that allows it to bind calcium into the bone matrix. When vitamin K is insufficient, osteocalcin circulates in an undercarboxylated form that is less effective at holding calcium where it belongs.13Thrombosis and Haemostasis. Serum Osteocalcin as a Marker for Vitamin K-Status in Pregnant Women and Their Newborn Babies For the mother, this is relevant because pregnancy already places significant demands on the skeleton. For the fetus, whose bones are forming rapidly in the third trimester, adequate activation of bone proteins matters for skeletal development. Whether routine K2 supplementation during pregnancy improves outcomes is still an open question, as large randomized trials have not been conducted, but the biochemical logic is sound.
Breastfeeding and the Vitamin K Gap
After birth, how you feed your baby continues to influence their vitamin K status. Breast milk is famously low in vitamin K. Measurements of vitamin K1 in breast milk hover around 2 to 3 nanomoles per liter, which is quite modest, and exclusively breastfed infants remain at higher risk for late-onset VKDB compared to formula-fed babies.14PubMed. The effect of formula versus breast feeding and exogenous vitamin K1 supplementation on circulating levels of vitamin K1 and vitamin K-dependent clotting factors in newborns Formula, by contrast, is fortified with vitamin K, and formula-fed infants reach normal adult-range vitamin K1 levels within the first days of life.
This does not mean breastfeeding is a problem to solve. It means the vitamin K shot at birth is especially important for breastfed babies, because it provides the depot that carries them through the months when breast milk alone would leave a gap. For mothers who chose an oral regimen instead, the continued weekly dosing for three months becomes even more critical if the baby is exclusively breastfed. Some countries have also explored whether increasing the mother’s vitamin K intake during lactation raises breast milk levels enough to matter. The effect exists but is modest, and no health authority currently recommends relying on maternal supplementation as a substitute for direct infant prophylaxis.
Practical Steps for Your Pregnancy
Most of what you need to do about vitamin K during pregnancy is reassuringly simple. Eating green vegetables regularly, something like a daily serving of spinach, kale, broccoli, or even a mixed green salad, puts you well above the recommended intake. If you eat fermented foods like certain cheeses or natto, you are also getting some K2. There is no established upper limit for vitamin K from food, and toxicity from dietary sources has not been reported, so there is no reason to hold back on leafy greens.
The situations where you need to be more proactive are specific. If you have hyperemesis gravidarum and are unable to keep food down for extended periods, ask your care team about checking your coagulation status and whether vitamin K supplementation is appropriate. If you take anticonvulsant medications, your provider should already be aware of the vitamin K interaction, but it is worth raising the topic explicitly, particularly as you approach the third trimester. If you have a malabsorption condition affecting fat digestion, vitamin K absorption may be compromised because it is a fat-soluble vitamin that requires bile salts to be taken up in the intestine.
After delivery, consenting to the vitamin K injection for your newborn is the single most impactful decision related to this nutrient. The shot has been given to millions of babies worldwide since the mid-twentieth century, its safety profile is well established, and it effectively eliminates the risk of a bleeding disorder that, while uncommon, can be catastrophic when it occurs.
A Brief History of How We Got Here
The connection between newborn bleeding and what we now call vitamin K took decades to unravel. The term “haemorrhagic disease of the newborn” was coined in 1894, but the underlying cause remained a mystery until the 1930s, when Danish researcher Henrik Dam and others identified a fat-soluble factor essential for blood clotting. Dam named it “Koagulation vitamin,” shortened to vitamin K, and the discovery eventually earned him a Nobel Prize.15PubMed. Vitamin K deficiency bleeding: early history and recent trends in the United Kingdom Prophylactic treatment of newborns followed relatively quickly in historical terms, and by the 1960s the practice was becoming standard in many countries. The fact that we now have countries debating oral versus injection regimens, rather than whether to give vitamin K at all, reflects how completely the science has established the need. The remaining questions are about optimization: the best form, the best dose, and how to ensure every newborn actually receives it regardless of where they are born or what their parents have read online.